Celltrion | 068270 - 贷款资金

金融业

KRW

KRW 768.81B

现金及等价物

KRW 56.79B

KRW 92.83B

KRW 481.57B

KRW 292.71B

KRW 160.58B

股息收益率

0.38

KRW 13.41B

KRW 19.64B

1.07K

EPS每股收益

KRW 1.35K

股本和储备

KRW 434.82B

KRW 39.29B

债务利息支出

KRW 19B

KRW 779.01M

KRW 411.27B

KRW 39525.85B

KRW 8.82B

KRW 119.22B

KRW 12.9B

普通股股本

KRW 229.65M

58.97

KRW 11.84B

KRW 1240B

销售和管理费用

KRW 9.32B

KRW 126B

贸易债权人

KRW 88.58B

应收帐款人

KRW 2009.82B

	贷款资金	更改		日
Akebia Therapeutics	USD 24.75M		11.64M	2026-06
Alaunos Therapeutics	USD 4.47M		5.85M	2022-06
Avita Medical	AUD 42.24M		1.25M	2024-12
Celltrion	KRW 411.27B		998.23M	2026-03
Dianthus Therapeutics	USD 0		0	2024-12
Ionis Pharmaceuticals	USD 1.91B		6.62M	2026-06
IQVIA Holdings	USD 13.7B		284M	2026-06
Moderna	USD 597M		6M	2026-06
Organon & Co	USD 8.48B		74M	2026-06
Revvity	USD 2.63B		1.02M	2026-06
Tectonic Therapeutic	USD 17K		26K	2026-03
Viatris	USD 11.61B		801.1M	2026-06
Xeris Pharmaceuticals	USD 188.81M		32.42M	2026-06